Category: 2024

Femasys is committed to providing women with revolutionary healthcare products: CEO

Bloomberg Businessweek: Medical Tech for Women

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

FemaSeed Shows Positive Results for Infertility Treatment

FemaSeed: A Breakthrough Solution Proving Promise in Overcoming Infertility Challenges

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

Alabama Ruling, Political Blowback Rattle In Vitro Fertilization Market

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF